INSP logo

Inspire Medical Systems (INSP) EBITDA

annual EBITDA:

$65.03M+$82.08M(+481.15%)
December 31, 2024

Summary

  • As of today (July 3, 2025), INSP annual EBITDA is $65.03 million, with the most recent change of +$82.08 million (+481.15%) on December 31, 2024.
  • During the last 3 years, INSP annual EBITDA has risen by +$103.65 million (+268.35%).
  • INSP annual EBITDA is now at all-time high.

Performance

INSP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

quarterly EBITDA:

$1.56M-$55.20M(-97.25%)
March 31, 2025

Summary

  • As of today (July 3, 2025), INSP quarterly EBITDA is $1.56 million, with the most recent change of -$55.20 million (-97.25%) on March 31, 2025.
  • Over the past year, INSP quarterly EBITDA has increased by +$15.94 million (+110.84%).
  • INSP quarterly EBITDA is now -97.25% below its all-time high of $56.75 million, reached on December 31, 2024.

Performance

INSP quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

TTM EBITDA:

$80.96M+$15.94M(+24.51%)
March 31, 2025

Summary

  • As of today (July 3, 2025), INSP TTM EBITDA is $80.96 million, with the most recent change of +$15.94 million (+24.51%) on March 31, 2025.
  • Over the past year, INSP TTM EBITDA has increased by +$93.50 million (+745.95%).
  • INSP TTM EBITDA is now at all-time high.

Performance

INSP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+481.1%+110.8%+746.0%
3 y3 years+268.4%+109.9%+308.1%
5 y5 years+312.6%+110.0%+250.3%

INSP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+259.6%-97.3%+108.3%at high+274.4%
5 y5-yearat high+220.1%-97.3%+107.0%at high+245.1%
alltimeall timeat high+220.1%-97.3%+107.0%at high+245.1%

INSP EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.56M(-97.3%)
$80.96M(+24.5%)
Dec 2024
$65.03M(-481.2%)
$56.75M(+251.0%)
$65.03M(+67.8%)
Sep 2024
-
$16.17M(+149.4%)
$38.75M(+291.9%)
Jun 2024
-
$6.48M(-145.1%)
$9.89M(-178.9%)
Mar 2024
-
-$14.38M(-147.2%)
-$12.53M(-26.5%)
Dec 2023
-$17.06M(-58.1%)
$30.48M(-340.1%)
-$17.06M(-61.0%)
Sep 2023
-
-$12.69M(-20.4%)
-$43.70M(-5.9%)
Jun 2023
-
-$15.94M(-15.7%)
-$46.43M(+5.7%)
Mar 2023
-
-$18.91M(-591.8%)
-$43.93M(+7.8%)
Dec 2022
-$40.73M(+5.5%)
$3.84M(-124.9%)
-$40.73M(-11.6%)
Sep 2022
-
-$15.43M(+14.8%)
-$46.07M(+14.9%)
Jun 2022
-
-$13.44M(-14.5%)
-$40.10M(+3.1%)
Mar 2022
-
-$15.71M(+954.9%)
-$38.90M(+0.7%)
Dec 2021
-$38.62M(-28.6%)
-$1.49M(-84.3%)
-$38.62M(-11.8%)
Sep 2021
-
-$9.47M(-22.5%)
-$43.80M(-0.2%)
Jun 2021
-
-$12.23M(-20.8%)
-$43.89M(-18.8%)
Mar 2021
-
-$15.44M(+131.4%)
-$54.03M(-0.2%)
DateAnnualQuarterlyTTM
Dec 2020
-$54.13M(+77.0%)
-$6.67M(-30.2%)
-$54.13M(-3.0%)
Sep 2020
-
-$9.55M(-57.3%)
-$55.82M(+3.7%)
Jun 2020
-
-$22.38M(+44.0%)
-$53.85M(+39.9%)
Mar 2020
-
-$15.53M(+85.9%)
-$38.50M(+25.8%)
Dec 2019
-$30.59M(+68.7%)
-$8.36M(+10.2%)
-$30.59M(+16.7%)
Sep 2019
-
-$7.58M(+8.0%)
-$26.22M(+16.3%)
Jun 2019
-
-$7.02M(-7.9%)
-$22.54M(+8.7%)
Mar 2019
-
-$7.63M(+91.4%)
-$20.73M(+14.3%)
Dec 2018
-$18.13M(+17.2%)
-$3.98M(+1.8%)
-$18.13M(+2.1%)
Sep 2018
-
-$3.91M(-24.9%)
-$17.76M(+2.3%)
Jun 2018
-
-$5.21M(+3.6%)
-$17.36M(+5.7%)
Mar 2018
-
-$5.03M(+39.2%)
-$16.43M(+6.2%)
Dec 2017
-$15.47M(-9.6%)
-$3.61M(+2.6%)
-$15.47M(+30.4%)
Sep 2017
-
-$3.52M(-17.7%)
-$11.86M(+42.2%)
Jun 2017
-
-$4.28M(+5.3%)
-$8.34M(+105.3%)
Mar 2017
-
-$4.06M
-$4.06M
Dec 2016
-$17.12M(-12.9%)
-
-
Dec 2015
-$19.65M
-
-

FAQ

  • What is Inspire Medical Systems annual EBITDA?
  • What is the all time high annual EBITDA for Inspire Medical Systems?
  • What is Inspire Medical Systems annual EBITDA year-on-year change?
  • What is Inspire Medical Systems quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Inspire Medical Systems?
  • What is Inspire Medical Systems quarterly EBITDA year-on-year change?
  • What is Inspire Medical Systems TTM EBITDA?
  • What is the all time high TTM EBITDA for Inspire Medical Systems?
  • What is Inspire Medical Systems TTM EBITDA year-on-year change?

What is Inspire Medical Systems annual EBITDA?

The current annual EBITDA of INSP is $65.03M

What is the all time high annual EBITDA for Inspire Medical Systems?

Inspire Medical Systems all-time high annual EBITDA is $65.03M

What is Inspire Medical Systems annual EBITDA year-on-year change?

Over the past year, INSP annual EBITDA has changed by +$82.08M (+481.15%)

What is Inspire Medical Systems quarterly EBITDA?

The current quarterly EBITDA of INSP is $1.56M

What is the all time high quarterly EBITDA for Inspire Medical Systems?

Inspire Medical Systems all-time high quarterly EBITDA is $56.75M

What is Inspire Medical Systems quarterly EBITDA year-on-year change?

Over the past year, INSP quarterly EBITDA has changed by +$15.94M (+110.84%)

What is Inspire Medical Systems TTM EBITDA?

The current TTM EBITDA of INSP is $80.96M

What is the all time high TTM EBITDA for Inspire Medical Systems?

Inspire Medical Systems all-time high TTM EBITDA is $80.96M

What is Inspire Medical Systems TTM EBITDA year-on-year change?

Over the past year, INSP TTM EBITDA has changed by +$93.50M (+745.95%)
On this page